Vivaldi 3: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes
Report setting out the results of a study of 124 staff and residents in 19 long term care homes who have received an mRNA booster following 2 doses of either Pfizer or AstraZeneca between May and November 2021